One Global buys 51% of Matrix Labs diagnostics arms in Rs 39.54 crore stock deal
What's the deal? One Global Service Provider LtdDealroom has a profile for this one. Try Dealroom → has approved the acquisition of a 51% controlling stake in two diagnostics firms, Matrix Labs DiagnocareDealroom has a profile for this one. Try Dealroom → and Matrix LabsDealroom has a profile for this one. Try Dealroom →. The Rs 39.54 crore deal is non-cash, settled by issuing 715,040 new equity shares to the sellers at Rs 553 each.
What's the endgame? One Global is pushing into medical diagnostics and In-Vitro Diagnostics (IVD) through inorganic growth. Folding in two established businesses gives it a foothold in both sectors and diversifies its revenue.
Why now? To fund the expansion, the board wants to double authorized share capital from Rs 25.05 crore to Rs 50 crore. Both moves go before shareholders at the 34th annual general meeting on September 29, 2026.
What could go wrong? The 715,040 new shares dilute existing holders. The entire transaction — plus the capital increase — still needs shareholder approval and pending regulatory clearances.
Governance note: Alongside the deal, the company reappointed S D P M & Co. as statutory auditor for a second five-year term. Valawat & Associates comes on as internal auditor for FY 2026-27, replacing Rushil Soni & Co., which resigned in August 2026.
The signal: Small listed players are using stock, not cash, to buy into India's growing diagnostics market — a route that preserves liquidity but tests shareholder appetite for dilution. The September 29 vote will decide whether One Global's bet clears.
Read more: whalesbook.com
Image credit: US Army Africa
